Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P980035/S849

Astra S DR MRI IPG; Astra S SR MRI IPG; Astra XT DR MRI IPG; Astra XT SR MRI IPG; Azure S DR MRI IPG; Azure S SR MRI IPG

Medtronic, Inc. · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONP980035/S849

What did the FDA decide?

The FDA recorded decision OK30 on 2026-10-29 for PMA supplement P980035/S849, submitted by Medtronic, Inc. as a 30-Day Notice. The supplement covers a series of battery electrolyte fill manufacturing process updates at Medtronic Energy and Components Center, filed under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The affected devices are the Astra S DR, Astra S SR, Astra XT DR, Astra XT SR, Azure S DR and Azure S SR MRI implantable pulse generators, classified as permanent implantable pulse generators (product code NVZ) in the cardiovascular specialty.

The supplement modifies a manufacturing step for the battery component rather than the pulse generator system as a whole, and the record does not establish a new approval of the complete device. The source data do not include the supplement documents, the specific electrolyte formulation or fill parameters changed, any performance testing, or the basis for the OK30 decision. Whether the updated process affects battery behavior in clinical use is not addressed in the available record.

Readers should treat this as a dated administrative record of a process change and not as evidence of changed clinical performance or labeling.

FDA approval order statement

a series of battery electrolyte fill manufacturing process updates at Medtronic Energy and Components Center
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 29, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P980035/S849
Regulatory pathway
PMA supplement
Product code
NVZ
Decision code
OK30
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulse generator, permanent, implantable.

Product code
NVZ
FDA device class
3

For the original device and its historical approval scope, see PMA P980035. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P980035 · Original PMA

    MEDTRONIC KAPPA 700/600 SERIES PULSE GENERATORS AND MODEL 9953 SOFTWARE

  2. P980035/S847 · Related supplement

    Astra S DR MRI IPG, Astra S SR MRI IPG, Astra XT SR MRI IPG, Azure S DR MRI IPG, Azure S SR MRI IPG, Azure XT DR MRI IPG

  3. P980035/S849 received

    Application receipt date recorded by FDA.

  4. P980035/S848 · Related supplement

    Astra S DR MRI IPG (X3DR01); Astra S SR MRI IPG (X3SR01); Astra XT DR MRI IPG (X1DR01); Astra XT SR MRI IPG (X1SR01); Az

  5. P980035/S849 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P980035. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P980035

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records